Article
Sadly, too many of our rheumatology colleagues passed on in 2022. Here is an (incomplete) list of notable brethren, mentors, do-gooders and great rheumatologists:
All News
Article
Dr. Jack Cush reviews the best of 2022 in Rheumatology - highlights on new drug indications, breakthrough lupus therapies, new biosimilars and the multivitamin letdown.
Article
2022 was a year of recovery, discovery, and some losses. While still dealing with the aftermath of COVID-19, rheumatologists were resilient as leaders for their patients and research in advancing rheumatologic care.
Article
Many Americans think of gout as a disease from a bygone era, akin to rickets or scurvy. The condition commonly afflicted the rich and royal, including American historical figures such as Benjamin Franklin and Thomas Jefferson.
Article
Reuters reports that in 2023, drug makers intend to increase the price of over 350 drugs.
Dr. John Cush
Tweet
In GCA, Hospital Admission Is Bad News
1/3 of patients admitted w/ GCA were rehospitalized within 6 months, largely because of complications potentially related to corticosteroid therapy, researchers found in a retrospective cohort study.
https://t.co/zaWZn7F9sl https://t.co/OfuyZxNbaa
Dr. John Cush
Tweet
Join us for RheumNow Live this March 18-19 in Dallas, TX! We're not like other meetings--we're answering the questions you want answered.
RNL is a meeting to engage your mind and change your practice. Join us in-person or virtually!
https://t.co/bMphD12Bie https://t.co/Hx0uHAIUWd
Dr. John Cush
Tweet
ACP Recommends Bisphosphonates as Initial Therapy for Osteoporosis
The guideline is based on a systemic review and network meta-analysis conducted by the ACP Center for Evidence Reviews at the Portland Veteran Affairs Research Foundation.
https://t.co/Pbsjuh1Bto https://t.co/IwcH04LS4n
Dr. John Cush
Tweet
2022 Match - Strong Appeal of Adult Rheumatology, Less So in Pediatric Rheumatology
The ACR is pleased to announce another successful recruitment season and welcomes this impressive pool of applicants to the field of rheumatology.
https://t.co/XEQCq5Pnnt https://t.co/quvxT9njI4
Dr. John Cush
Tweet
Extreme Global Costs of Physical Inactivity
A global, population-based study shows that physical inactivity is not only an important modifiable risk factor for NCDs and mental health conditions, it also imparts a considerable health and economic burden.
https… https://t.co/eZEW6LGpiL
Dr. John Cush
Tweet
Should Kids w/ MIS-C get the COVID vaccine? Yes - study of 385 pt > 5 yrs w/ Hx of multisystem inflammatory syndrome showed no serious adverse events after COVID-19 vaccination. The safety profile of COVID-19 vax is same as gen population https://t.co/dr2QBQsMhE? https://t.co/WbsUuYEsez
Dr. John Cush
Tweet
The Dartmouth Hitchcock Medical Center (DHMC) is searching for a new Chief of the Section of Rheumatology - one who is dynamic, experienced, future-oriented academic Rheumatologist https://t.co/TD6gjWAzZu https://t.co/p4NSe6VtKD
Dr. John Cush
Tweet
The Daily Mail in the UK features a long review of Hx of #Gout (Disease of Kings) & being on the rise in the UK - features a video interview with Professor Philip Conahan (one of our speakers at RheumNow Live 2023!) https://t.co/dNC71DwXTf https://t.co/ZtmQgx5aHc https://t.co/2D3HE0GFO5
Dr. John Cush
Tweet
Weekly (Ozempic) semaglutide SC was given for obesity, 3-6 mos to 408 pts with BMI> 27. Wt loss was 5.9% (6.7 kg) @3 mos & 10.9% (12.3 kg) @6 mos. 55%) had >10% & 8% had > 20% wt loss. NIDDM pts had less wt loss vs non-DM pts. https://t.co/05O6hlNm2G https://t.co/ppxjLOE03B
Dr. John Cush
Tweet
520 RA pts were screened with FibroScan (liver fibrosis)- F3 or F4 liver fibrosis seen 13.3% of controls vs 12.7% arthritis pts. MTX was not significantly correlated w/ higher FS scores. Liver stiffness was correlated w/ BMI, waist, male , age. https://t.co/NzXfbYsXUu
RWCS
Tweet
RWCS 2023, Ask the Consultant: Join speakers Anna Postolova, MD & Uma Mahadevan, MD (.@UmaMahadevanIBD) as they cover crucial topics from their personal perspectives, supplemented by literature review, followed by audience Q&A, & discussion. Register here: https… https://t.co/CLqysAAfpA
Dr. John Cush
Tweet
Dr. Kristi Kuhn & Univ of Colorado researchers have linked RA risk with the gut bacterium Subdoligranulum didolesgii. This could be pathogenically important and supports their "Mucosal origins hypothesis" to RA risk https://t.co/xDyejVR8MW https://t.co/M663ziXOcT https://t.co/y7zpukZah5
Dr. John Cush
Tweet
Differential Dx of hyperferritinemia (≥500 μg/) in critically ill ICU pts includes: sepsis, liver disease/failure, hematological malignancy, HLH. Single center study of 2583 patients https://t.co/yuqJcyLIP5 https://t.co/vHLqJGP4mv
Dr. John Cush
Tweet
40 yoF with Chronic cough and dyspnea - Lung Fibrosis in Systemic Sclerosis https://t.co/4NYa0l9Dci https://t.co/XTDLKPtrkH
Dr. John Cush
Tweet
Rheums manage #RA. But patients have to manage RA and their lives - I wish we could provide better guidance to our patients about Life with RA. Heres one patient from Wash, DC who accomplished SO MUCH in 2022 and she has RA! @hirokonishimura https://t.co/QStFGZLsTR https://t.co/Q7GoYQYvwx
